This will be a (2 visit) double-blind, randomized, placebo crossover design clinical study to assess the potential benefits of FSD-F2R6-A-CP versus a placebo by assessing its impact on side effect profiles as well as cognitive abilities, motor abilities, and breath alcohol concentration following ingestion of alcohol followed by the dietary supplement or placebo. This study will enroll healthy men and women.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Intoxication
Timeframe: Change in pre-treatment score to 0.5, 1, 2 and 4 hours post-treatment
Impairment
Timeframe: Change in pre-treatment score to 0.5, 1, 2 and 4 hours post-treatment
Mental Fatigue
Timeframe: Change in pre-treatment score to 0.5, 1, 2 and4 hours post-treatment
Clearheaded-Muzzy
Timeframe: Change in pre-treatment score to 0.5, 1, 2 and 4 hours post-treatment
Clumsy-Well Coordinated
Timeframe: Change in pre-treatment score to 0.5, 1, 2 and 4 hours post-treatment
Energetic-Lethargic
Timeframe: Change in pre-treatment score to 0.5, 1, 2 an 4 hours post-treatment
Drowsy-Alert
Timeframe: Change in pre-treatment score to 0.5, 1, 2 an 4 hours post-treatment
Mentally Slow-Quick Witted
Timeframe: Change in pre-treatment score to 0.5, 1, 2 and 4 hours post-treatment
Headache
Timeframe: Change in pre-treatment score to 0.5, 1, 2, 4 and 8 hours post-treatment